|
CYR61 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.157400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.222490E-02 |
| Normal-vs-Stage2 |
5.500000E-03 |
| Normal-vs-Stage3 |
3.962000E-04 |
| Normal-vs-Stage4 |
2.13349999999002E-05 |
| Stage1-vs-Stage2 |
3.653000E-01 |
| Stage1-vs-Stage3 |
1.546760E-01 |
| Stage1-vs-Stage4 |
1.103890E-02 |
| Stage2-vs-Stage3 |
8.909400E-01 |
| Stage2-vs-Stage4 |
3.373600E-01 |
| Stage3-vs-Stage4 |
3.232400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.003100E-04 |
| Normal-vs-AfricanAmerican |
1.142050E-02 |
| Normal-vs-Asian |
2.291700E-02 |
| Caucasian-vs-AfricanAmerican |
7.266800E-01 |
| Caucasian-vs-Asian |
2.533400E-01 |
| AfricanAmerican-vs-Asian |
1.850980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.31189999999604E-05 |
| Normal-vs-Female |
8.629900E-02 |
| Male-vs-Female |
2.478100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.093500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.86730000000846E-05 |
| Normal-vs-Age(61-80Yrs) |
4.984200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.886300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.583400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.229400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.604800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.963000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.301600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.202200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.153000E-01 |
| Normal-vs-Grade 2 |
1.024490E-02 |
| Normal-vs-Grade 3 |
4.618500E-04 |
| Normal-vs-Grade 4 |
1.80371999999318E-05 |
| Grade 1-vs-Grade 2 |
4.016000E-01 |
| Grade 1-vs-Grade 3 |
3.710200E-01 |
| Grade 1-vs-Grade 4 |
1.809360E-01 |
| Grade 2-vs-Grade 3 |
2.414600E-01 |
| Grade 2-vs-Grade 4 |
8.521300E-03 |
| Grade 3-vs-Grade 4 |
1.189760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.519500E-02 |
| Normal-vs-ccB subtype |
2.51009999996388E-06 |
| ccA subtype-vs-ccB subtype |
1.003170E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.959200E-04 |
| Normal-vs-N1 |
3.68549968321474E-10 |
| N0-vs-N1 |
4.19829999998012E-06 |
|
|
